Has John Eidt, MD received payments from drug or device companies?

Yes. Drug and device makers reported $99,646 in general payments to John Eidt, MD across 585 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Eidt, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Eidt, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Eidt, MD

Vascular Surgery · Dallas, TXNPI 1932115987

Payments from drug & device makers

$99,646in general payments, 2019–2025

Across 585 payments — averaging $170.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

W. L. Gore & Associates, Inc.$48K
Medtronic$13K
Neuros Medical, Inc.$11K
Penumbra, Inc.$8K
Cvrx, Inc.$8K
Endologix LLC$2K
plus $10K from 54 others

$1,050in research payments, 2019–2025

Across 2 payments — averaging $525.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Terumo Medical Corporation$1K

What the payments were for

Consulting fees$55,30063%
Speaking & faculty fees$6,0237%
Travel & lodging$3,0543%
Food & beverage$23,16926%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
W. L. Gore & Associates, Inc.	155	$48,158
Medtronic(2 entities)	54	$13,457
Neuros Medical, Inc.	25	$10,917
Penumbra, Inc.	14	$7,638
Cvrx, Inc.	24	$7,575
Endologix LLC	15	$2,366
Bolton Medical Inc	39	$1,833
Cook Medical LLC	19	$791
Tactile Systems Technology Inc	30	$686
Silk Road Medical, Inc.	9	$595
Axogen	22	$505
Johnson & Johnson(2 entities)	26	$464
Limflow Inc.	2	$348
E.r. Squibb & Sons, L.L.C.	23	$321
Pfizer	20	$291
Baylis Medical Technologies Inc.	4	$290
Livanova USA, Inc.	3	$286
Stryker	6	$282
Angiodynamics, Inc.	5	$218
Bard Peripheral Vascular, Inc.	3	$210
Imperative Care, Inc	7	$206
Terumo Medical Corporation	2	$182
Shockwave Medical, Inc	1	$163
Sirtex Medical Inc	8	$140
Baxter Healthcare	5	$139
Abbott	6	$132
Cardiovascular Systems Inc.	1	$125
Balt USA, LLC	4	$85
Boston Scientific	2	$80
Surmodics, Inc.	3	$78
Kerecis Limited	1	$74
Philips North America LLC	3	$72
Avinger Inc.	3	$72
Lemaitre Vascular, Inc.	2	$62
AstraZeneca	3	$58
Cardiva Medical, Inc.	2	$57
KCI USA, Inc.	3	$53
Ossur Americas, Inc.	2	$52
Resmed Corp	2	$46
Novartis	2	$43
Innovation Technologies Inc	1	$39
Inspiremd Ltd	2	$38
Cardinal Health 200 LLC	1	$38
Integra Lifesciences Corporation	2	$36
Smith+Nephew	2	$35
Acell, Inc.	2	$32
BD	1	$31
Reflow Medical Inc	2	$31
Aroa Biosurgery Incorporated	1	$30
Acacia Pharma Inc	1	$22
B. Braun Interventional Systems Inc.	1	$22
Acera Surgical, Inc.	1	$20
Acist Medical Systems, Inc.	1	$20
Davol Inc.	1	$18
Venturemed Group, Inc.	1	$18
Merit Medical Systems Inc	1	$15
Covidien LP	1	$15
Cashflow Solutions, LLC	1	$14
Mallinckrodt Hospital Products Inc.	1	$14
Getinge USA Sales, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,646 in reported general payments places this provider in the 90th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$54,641

Medicare patients

122

Services billed

278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	18	$181

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Dallas

Gregory PearlDallas$2.3M
Michael SiahDallas$838K
Stephen HohmannDallas$587K
Dennis GableDallas$547K
Carlos TimaranDallas$527K
William ShutzeDallas$106K
Bradley GrimsleyDallas$101K
John KedoraDallas$101K
Alton BurnsDallas$98K
Javier VasquezDallas$92K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →